SCHEMBL9289229

SCHEMBL9289229

Cc1nc(N)nc(C)c1-c1ccccc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ HPGD P15428 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ NUDT1 P36639 1/20 0.55
▸ ADORA2A P29274 3/20 0.52
▸ ADORA1 P30542 2/20 0.52
▸ POLB P06746 1/20 0.52
▸ ADORA3 P0DMS8 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ BRD4 O60885 2/20 0.52
▸ TDO2 P48775 1/20 0.52
▸ DHFR P00374 2/20 0.52
▸ HEXA P06865 1/20 0.52
▸ HEXB P07686 1/20 0.52
▸ NPC1 O15118 4/20 0.51
▸ RAB9A P51151 3/20 0.51
▸ MAPT P10636 2/20 0.51
▸ HTT P42858 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3500167 0.90 DHFR (0.61) ALDH1A1HPGDHSD17B10CYP1A2NUDT1
SCHEMBL12368269 0.83 HEXA (0.73) ALDH1A1CYP1A2DHFRHEXAHEXB
SCHEMBL15429573 0.83 HPGD (0.45) ALDH1A1HPGDHSD17B10CYP1A2NUDT1
SCHEMBL30166674 0.83 ALDH1A1 (0.45) ALDH1A1HPGDHSD17B10CYP1A2NUDT1
SCHEMBL19160148 0.82 HEXA (0.55) ALDH1A1HPGDHSD17B10CYP1A2NUDT1
SCHEMBL89125 0.79 L3MBTL1 (0.60) ALDH1A1HPGDADORA2AADORA1POLB
SCHEMBL6530612 0.78 HSD17B10 (0.56) ALDH1A1HPGDHSD17B10CYP1A2NUDT1
SCHEMBL27459436 0.78 SMN1; SMN2 (0.56) ALDH1A1HPGDHSD17B10NPC1RAB9A
SCHEMBL11313288 0.77 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10ADORA2ABRD4
SCHEMBL9286817 0.77 ADORA2A (0.50) ADORA2AADORA1ADORA2BDHFRHEXA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106046197-A Compound having bacteriostatic activity and preparation and application thereof 中国科学院海洋研究所 2016-10-26 — — CN disclosed
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-04-17 — — US disclosed
US-20140073628-A1 BENZOXAZEPINES ASN INHIBITORS OF P13K/M TOR AND METHODS OF THEIR USE AND MANUFACTURE RICE KENNETH D (US) 2014-03-13 — — US disclosed
US-20140018347-A1 BENZOXAZEPINES AS INHIBITORS OF mTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2014-01-16 — — US disclosed
WO-2012071511-A1 BENZOXAZEPINES AS INHIBITORS OF MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018347-A1 BENZOXAZEPINES AS INHIBITORS OF mTOR AND METHODS OF THEIR USE AND MANUFACTURE MTOR, RICTOR, RPTOR ALDH1A1 3330/4885HPGD 733/4885HSD17B10 1180/4885
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ALDH1A1 3533/4885HPGD 1161/4885HSD17B10 711/4885
US-20140073628-A1 BENZOXAZEPINES ASN INHIBITORS OF P13K/M TOR AND METHODS OF THEIR USE AND MANUFACTURE MTOR, RPTOR, RICTOR ALDH1A1 4794/4885HPGD 3707/4885HSD17B10 3728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback